NIA Predoctoral Fellowship Award to Promote Diversity in Translational Research for AD/ADRD (F31)

Funding Agency:
National Institutes of Health

The purpose of this Funding Opportunity Announcement (FOA) is to promote diversity in the translational research workforce for Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD). This predoctoral fellowship program will emphasize the development of skills in data science and drug discovery and their application to various aspects of AD/ADRD research (from populations studies to research that can lead to new treatments and diagnostics, including all aspects of behavioral and social research). It will support research training of promising predoctoral candidates from diverse backgrounds to help them gain critical translational skills in data science and drug discovery. The long-term goal of this program is to develop a diverse translational workforce that can effectively participate in and/or lead a team-science, precision medicine approach to studies of AD/ADRD treatment, prevention, early detection, and disease management and care.

 

This Funding Opportunity Announcement (FOA) does not allow applicants to propose to lead an independent clinical trial, but does allow applicants to propose research experience in a clinical trial led by a sponsor or co-sponsor.

Deadlines: Apr. 8, Aug. 8, Dec. 8

PAR-21-218 Expiration Date: August 09, 2024

Agency Website

Eligibility Requirements

Before submitting a fellowship application, the candidate must identify a sponsoring institution. The sponsoring institution must have staff and facilities available on site to provide a suitable environment for performing high-quality research training. The training should occur in an environment that has appropriate human and technical resources and is demonstrably committed to training in the field(s) proposed by the candidate. The sponsoring institution may be private (profit or nonprofit) or public, including the NIH Intramural Programs and other Federal laboratories. All institutions with the appropriate resources and commitment are encouraged to apply.

The goal of this program is to promote diversity in the translational research workforce for AD/ADRD. Fostering diversity by addressing underrepresentation in the scientific research workforce is a key component of the NIH strategy to identify, develop, support, and maintain the quality of our scientific human capital. Despite tremendous advancements in scientific research, information, educational, and research opportunities are not equally available to all. ).

For the purpose of this announcement, institutions are encouraged to identify candidates who will enhance diversity on a national basis. In addition, it is recognized that underrepresentation can vary from setting to setting; individuals from racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution should be encouraged to participate in this program.

 

The candidate must be at the dissertation research stage of training at the time of award and must show evidence of high academic performance in the sciences, and commitment to a career as an independent research scientist.

The candidate must be currently enrolled in a PhD or equivalent research degree program (e.g., EngD, DNSc, DrPH, DSW, PharmD, ScD) in the biomedical, behavioral, or clinical sciences at a domestic or foreign institution.

Students matriculated in a dual-degree program (e.g. MD/PhD, DO/PhD, DDS/PhD, or DVM/PhD) who seek support for both dissertation research training and clinical training are not eligible for this Kirschstein-NRSA F31 program because this F31 program does not support the clinical training component of a dual-degree program. Such students may apply for the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral MD/PhD or Other Dual-Doctoral Degree Fellowship (Parent F30) to support both dissertation research training and clinical training.

Funding Type

Award
Fellowship
Grant

Eligibility

African American
Disabled
Grad/Prof Students
Hispanic
Native American
Women of Color

Category

Medical
Medical - Clinical Science
Medical - Translational

External Deadline

April 8, 2024